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Abstract
Ribosome profiling is widely used to study translation in vivo, but not all sequence reads 
correspond to ribosome-protected RNA. Here, we develop Rfoot, a computational pipeline that 
analyzes ribosomal profiling data and identifies native, non-ribosomal RNA-protein complexes in 
the same sample.. We use Rfoot to precisely map RNase-protected regions within small nucleolar 
RNAs, spliceosomal RNAs, microRNAs, tRNAs, long noncoding (lnc) RNAs, and 3’ˊ 
untranslated regions of mRNAs in human cells. We show that RNAs of the same class can show 
differential complex association. Although only a subset of lncRNAs show RNase footprints, 
many of these have multiple footprints, and the protected regions are evolutionarily conserved, 
suggestive of biological functions.
Target sites for individual RNA-binding proteins have been identified on a transcriptome 
scale using CLIP-seq (crosslinking and immunoprecipitation-seq) or PAR-CLIP 
(photoactivable ribonucleoside-enhanced CLIP) techniques1,2. Two transcriptome-scale 
methods for more comprehensive identification of RNA-protein interactions in vivo have 
been described. One approach uses UV crosslinking of cells grown in the presence of 4-
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thiouridine3,4, but this is limited to short-range interactions of appropriate stereochemistry to 
permit UV crosslinking. The other approach involves RNase footprinting of RNA 
crosslinked with formaldehyde5. Both transcriptome-scale approaches map the regions of 
RNA bound by proteins in the context of the RNA-protein complex, but they do not identify 
the specific proteins involved. In addition, both methods identify bound regions on a 
population basis, not at the levels of individual molecules, and hence cannot distinguish 
between different complexes associated with the same region of RNA.
Sequencing of ribosome-protected RNA, known as ribosome profiling, has been used widely 
to examine translation in vivo6. In this procedure, cell extracts are treated with RNase I to 
degrade all non-protected RNA, and the resulting material is subjected to velocity 
sedimentation through sucrose to enrich for material > 7–10S (corresponds to a 100–200 
kDa globular protein) while removing degraded RNA and other low-molecular-weight 
material. In the course of ribosome profiling experiments, we and others noted that many 
sequencing reads do not correspond to translated regions. Ribosomes are not specifically 
selected during the biochemical isolation procedure, and therefore non-ribosomal RNA-
protein complexes should also be present. In ribosome profiling, sequencing reads 
correspond to ribosomes that span the entire translated region and show 3-nt periodicity 
(Fig. 1a). In contrast, sequencing reads corresponding to RNase footprints of non-ribosomal 
RNA-protein complexes should be highly localized (Fig. 1a,b). Each RNA species has a 
percentage of maximum entity (PME) value that reflects degree of localization of sequence 
reads within this RNA (0 represents highly localized and 1 represents uniform distribution 
across the gene), and different types of RNA–protein complexes have different PME values 
(Fig. 1b).
Based on these considerations, we develop a computational pipeline, Rfoot (Supplementary 
Code), to systematically identify RNA regions protected by non-ribosomal protein 
complexes. Specifically, Rfoot searches for protected RNA regions with at least 10 
sequencing reads that are highly localized and do not show 3-nt periodicity. Rfoot is distinct 
from standard peak- detecting methods in ChIP-seq and CLIP-seq analyses that respectively 
identify DNA or RNA regions bound by proteins. Rfoot considers read distribution patterns 
and distinguishes between RNA protected by ribosomes, which represent the majority of 
sequence reads, from RNA protected by non-ribosomal complexes. Unlike analyses of ChIP-
seq and CLIP-seq data that require peak detection methods to map bound regions from a 
population of molecules of varying size with endpoints having varying distances from the 
protected region, each sequencing read in Rfoot analysis corresponds directly to the fully 
protected region of an individual RNA-protein complex.
Rfoot analysis of our previous ribosome profiling data7 from two isogenic human cancer cell 
models (Src-inducible mammary epithelial and Ras-dependent fibroblast;)8 reveals that 
11.3% of the sequencing reads correspond to non-ribosomal RNA-protein complexes. 
Protected RNA regions, and presumably RNA-protein complexes, are observed for virtually 
all types of cytoplasmic and nuclear RNAs: mRNAs (3’ UTRs); lncRNAs; small nucleolar 
(sno) RNAs; spliceosomal RNAs; microRNAs; and tRNAs. Detection of a given RNA–
protein complex depends on the abundance of the RNA, the fraction of RNA stably bound 
by proteins throughout the experimental procedure, and the total number of sequencing 
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reads. Although the sequencing depth used here is sufficient to identify RNA–protein 
complexes from all RNA classes, greater sequencing depth would likely reveal additional 
complexes involving mRNAs, miRNAs or lncRNAs that are poorly expressed. As expected, 
different types of RNA–protein complexes protect different lengths of RNAs (Fig. 1c), and 
the same complexes are observed when translation was inhibited by either cycloheximide or 
harringtonine.
Small nucleolar (sno) RNAs are primarily nuclear, with the C/D box snoRNAs guiding 
methylation and the H/ACA box class guiding pseudouridylation of other RNAs9. We 
identified RNase footprints for 112 C/D box RNAs and 68 H/ACA box RNAs (Table S1), 
which represent almost all expressed snoRNAs. The protected region of C/D type snoRNAs 
covers the stem loop structure between the C motif (UGAUGA) and D motif (CUGA) (Fig. 
2a,b). The region between C/D motifs forms an RNA duplex with the methylation site of the 
target RNA10, and is bound by C/D ribonucleoproteins9. Notably, although C/D box 
snoRNAs can form symmetric stem loop structures (Fig. 2a), the protected region covers the 
left arm of SNORD105, the right arm of SNORD110, and both arms for SNORD113–9, and 
the middle D and C motifs from different arms of SNORD87 (Fig. 2b). For H/ACA type 
snoRNAs, the protected regions flank the H box (ANANNA), the single stranded region 
linking two stem loop structures, and the ACA box located in the tail region (Fig. 2c,d). 
These motifs are bound by the H/ACA ribonucleoproteins9. Interestingly, although C/D box 
snoRNAs can form symmetric stem loop structures (Fig. 2a), the protected region covers the 
left arm of SNORD105, the right arm of SNORD110, and both arms for SNORD113-9, and 
the middle D and C motifs from different arms of SNORD87 (Fig. 2b). For H/ACA type 
snoRNAs, the protected regions flank the H box (ANANNA), the single stranded region 
linking two stem loop structures, and the ACA box located in the tail region (Fig. 2c, d). 
Reads in SNORA23 are mostly in the H box (Fig. 2d), whereas reads in SNORA3 are more 
associated with ACA box (Fig. 2d). Thus, it appears that RNA–protein complexes within an 
individual snoRNA class can have different stabilities or conformations.
Spliceosomal RNAs associate with spliceosomal proteins to form small nuclear ribonucleic 
particles (snRNPs) that are critical for RNA splicing11, and we detected RNase footprints for 
all types of spliceosomal RNAs (Table S1). For RNU11, the protected region is mainly 
associated with the Sm site (Fig. 2e), a conserved sequence (consensus AUUUGUGG) 
bound by the SMN complex12. For RNU12, protected regions are observed both for the Sm 
site and the 5’ hairpin structure (Fig. 2f) that interacts with branch points of pre-mRNA12.
We detected RNase footprints for almost all expressed tRNAs (157 in Table S1). The 
protected regions are located in the D loop and TΨC loop. The D loop is recognized by 
aminoacytl-tRNA synthases13, whereas the TΨC loop is important for ribosome binding14. 
The read distribution between these loops varies among tRNAs. For example, more 
sequencing reads are observed for the D loop of tRNA9 on chromosome 1 (Figs. 2g,S1a), or 
the TΨC loop of tRNA2 on chromosome 12 (Figs. 2h,S1b). Thus, as observed for snoRNAs, 
tRNA–protein complexes can have different stabilities or conformations.
We detected RNase protected regions for 12 miRNAs (Table S1) that cover the mature 
microRNA (Fig. S2a,b). If one transcript encodes two mature miRNAs (e.g., miR21 and 
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miR21*), sequence reads were observed over both mature miRNAs (Fig. S2c). The RNA– 
induced silencing complex (RISC) may bind to these regions, but it is unknown why RNase 
footprints are not detected for most expressed miRNAs.
The fact that mRNAs are associated with ribosomes makes it difficult to identify non-
ribosomal RNA–protein complexes that interact with protein-coding or non-canonical 
translated regions. In this regard, we found 95 protected RNA regions in 3’ UTRs of 69 
mRNAs (Table S1). For example, the protected RNA sequence in AMD1 3’ UTR also forms 
stable hairpin structure (Fig. S3).
Some lncRNAs interact with polycomb proteins, and it has been suggested that these 
interactions affect chromatin structure and transcription15,16. Although we detect RNase 
footprints for only 87 (8%) of expressed lncRNAs, this is five times as many footprints as 
observed for 3’ UTRs, even though the number of nucleotides in 3‘ UTRs is higher than in 
lincRNAs. Moreover, in this subset of 87 lncRNAs, we identified 208 non-ribosomal binding 
sites (Table S1), an average of 2.4 footprints/lncRNA. For example, the telomerase 
component TERC contains 3 non-ribosomal protein-binding sites (Fig. S4a) that cover the 
H- and CAB-boxes of the ScaRNA domain, and a 5’ single strand region (Fig. S4b), 
whereas MALAT1 shows several RNase footprints at regions tending to form RNA hairpin 
structures (Fig. 2i). Notably, one MALAT1 region shows two distinct RNAse footprints as 
defined by different protected fragment lengths (Fig. 2i) and a similar situation occurs at 
other lncRNAs (e.g., Fig. S5). Distinct RNase footprints over the same region could reflect 
completely different or related RNA–protein complexes or alternative conformations of the 
same complex. In addition, some RNA–protein complexes are cell-type specific (Figs. 2i, 
S5). Considering all RNase footprints in lncRNAs, PhastCon scores based on 44-vertebrate
Multiz alignment17 of nucleotide sequences reveals that the conservation level is about 2-
fold higher than surrounding sequences (Fig. 2j; Wilcoxon Rank-Sum Test P-value < 10−19). 
Taken together, these observations suggest that RNase footprints in lncRNAs may represent 
RNA-protein complexes that carry out biological functions.
Our experimental method differs from a transcriptome-scale RNase footprinting approach 
described previously5, and it is advantageous in several respects. First, by avoiding 
crosslinking, we are able to identify native RNA-protein complexes. Crosslinking can cause 
artifacts, although it also enables the detection of less stable complexes. Second, whole-cell 
extracts are subject to a crude purification step that enriches for RNA–protein complexes and 
removes degraded RNA, thereby eliminating sequence reads corresponding to RNA not 
associated with proteins. In principle, distinct RNA-protein complexes could be enriched by 
fractionation based on molecular weight or by immunoprecipitation with an antibody against 
a specific protein (analogous to CLIP-seq). In addition, factors important for RNase 
footprints can be identified by comparing cells depleted of an individual factor with their 
wild-type counterparts. Third, each sequencing read corresponds to a complete protected 
region for an individual RNA molecule. By examining the size distribution of the protected 
region of individual RNase footprints, we detected distinct RNA–protein complexes for 
some footprints of MALAT1 and several other lncRNAs. In contrast, RNase footprints 
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obtained with the previous approach represent averages over many molecules such that 
distinct RNA-protein complexes cannot be detected.
Our method can analyze reported and future ribosome profiling datasets for RNase 
footprints on non-ribosomal RNA-protein complexes. In this regard, we performed Rfoot 
analysis on published ribosomal profiling datasets from mouse cell lines18,19. In accord with 
our results in human cells, 14.5% of the reads of the sequencing reads correspond to non-
ribosomal RNA–protein complexes, and the PME profiles of the mouse (Fig. S6a) and 
human (Fig. 1b) samples are similar. Furthermore, RNA–protein complexes representing all 
types of RNA species are identified in these mouse cell lines, and the relative proportion of 
these types of complexes are roughly comparable to what we observed in human cells 
(compare Fig. 1d with Fig. S6b). The ability to analyze translation (ribosome footprints) and 
non- ribosomal RNA–protein complexes in the same sample cannot be done by other 
methods. Lastly, we note that most of the RNA–protein complexes identified here have not 
been described previously. As such, our method represents a distinct and complementary 
approach to identifying RNA–protein complexes on a transcriptome scale.
METHODS
Methods and any associated references are available in the online version of the paper.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
ACKNOWLEDGEMENTS
This work was supported by grants to K.S. from the National Institutes of Health (CA 107486). A.R. is a Howard 
Hughes Investigator.
References
1. Zhang C, Darnell RB. Mapping in vivo protein-RNA interactions at single-nucleotide resolution 
from HITS-CLIP data. Nat Biotechnol. 2011; 29:607–614. [PubMed: 21633356] 
2. Hafner M, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target 
sites by PAR-CLIP. Cell. 2010; 141:129–141. [PubMed: 20371350] 
3. Baltz AG, et al. The mRNA-bound proteome and its global occupancy profile on protein-coding 
transcripts. Mol. Cell. 2012; 46:674–690. [PubMed: 22681889] 
4. Freeberg MA, et al. Pervasive and dynamic protein binding sites of the mRNA transcriptome in 
Saccharomyces cerevisiae. Genome Biol. 2013; 14:R13. [PubMed: 23409723] 
5. Silverman IM, et al. RNase-mediated protein footprint sequencing reveals protein- binding sites 
throughout the human transcriptome. Genome Biol. 2014; 15:R3. [PubMed: 24393486] 
6. Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS. Genome-wide analysis in vivo of 
translation with nucleotide resolution using ribosome profiling. Science. 2009; 324:218–223. 
[PubMed: 19213877] 
7. Ji Z, Song R, Huang H, Regev A, Struhl K. Many lincRNAs are translated and some are likely to 
express functional proteins. eLife. submitted. 
8. Hirsch HA, et al. A transcriptional signature and common gene networks link cancer with lipid 
metabolism and diverse human diseases. Cancer Cell. 2010; 17:348–361. [PubMed: 20385360] 
Ji et al. Page 5





















9. Matera AG, Terns RM, Terns MP. Non-coding RNAs: lessons from the small nuclear and small 
nucleolar RNAs. Nat. Rev. Mol. Cell. Biol. 2007; 8:209–220. [PubMed: 17318225] 
10. Kiss-Laszlo Z, Henry Y, Kiss T. Sequence and structural elements of methylation guide snoRNAs 
essential for site-specific ribose methylation of pre-rRNA. The EMBO journal. 1998; 17:797–807. 
[PubMed: 9451004] 
11. Will CL, Luhrmann R. Splicesome structure and function. Cold Spring Harb. Perspect. Biol. 2011; 
3:a003707. [PubMed: 21441581] 
12. Russell AG, Charette JM, Spencer DF, Gray MW. An early evolutionary origin for the minor 
spliceosome. Nature. 2006; 443:863–866. [PubMed: 17051219] 
13. Hendrickson TL. Recognizing the D-loop of transfer RNA. Proc. Natl. Acad. Sci. U.S.A. 2001; 
98:13473–13475. [PubMed: 11717415] 
14. Peattie DA, Herr W. Chemical probing of the tRNA-ribosome complex. Proc. Natl. Acad. Sci. 
U.S.A. 1981; 78:2273–2277. [PubMed: 6166006] 
15. Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. 
Cell. 2013; 152:1298–1307. [PubMed: 23498938] 
16. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012; 
81:145–166. [PubMed: 22663078] 
17. Siepel A, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. 
Genome Res. 2005; 15:1034–1050. [PubMed: 16024819] 
18. Eichhorn SW, et al. mRNA destabilization is the dominant effect of mammalian microRNAs by the 
time substantial repression ensues. Mol. Cell. 2014; 56:104–115. [PubMed: 25263593] 
19. Diaz-Munoz MD, et al. The RNA-binding protein HuR is essential for the B cell antibody 
response. Nat. Immunol. 2015; 16:415–425. [PubMed: 25706746] 
Ji et al. Page 6





















Fig. 1. Identifying non-ribosomal protein associated footprints
(a) Read distribution pattern in translated ORFs and non-ribosomal RNA-protein complexes. 
(b) Distribution of PME values across transcripts (60nt window). (c) Read fragment length 
of RNase footprints in types of transcripts. (d) Fraction (in percent) of the various types of 
RNA-protein complexes.
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Fig. 2. Footprinted regions on various classes of RNA
(a) Structure of C/D box snoRNAs. (b) Read distribution of the indicated C/D box snoRNAs 
with respect to the C and D motifs. (c) Structure of H/ACA box snoRNAs. (d) Read 
distribution of the indicated H/ACA box snoRNAs with respect to the H and ACA motifs. 
Read distribution in (e) RNU11 and (f) RNU12 spliceosomal RNAs with respect to the 
indicated motifs and secondary structures. Read distribution in (g) chr1.tRNA9-ArgUCU 
and (h) chr12.tRNA2-SerCGA tRNAs with respect to the D and TΨC loops. (i) Read 
distribution in the MALAT1 lncRNA along with protected regions and PhastCon scores 
based on 44-vertebrate Multiz alignment. Read distributions in the indicated cell types and 
fragment lengths and RNA structures in two protected regions are shown. The two fragment 
length peaks in the protected region on the right indicate structurally and/or 
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conformationally distinct RNA-protein complexes. (j) Distribution of mean Phastcon scores 
around Lnc RNase footprints.
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